google-site-verification: googlec7193c3de77668c9.html

Blood-based marker opens up perspectives for cancer diagnostics

[
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation therapy. Reliable markers that can be used to predict aggressive tumor progression and treatment success at an early stage are still largely lacking.


Source link

Advertisements
Views: 1

See also  Ibuprofen and acetaminophen may fuel antibiotic resistance, study warns

Check Also

A good night’s sleep begins with healthy gut bacteria. Here’s how to look after yours

[ Credit: Pixabay/CC0 Public Domain It’s no accident that we spend a third of our …

Simple leukemia treatment change in India cuts early child deaths

[ A landmark Indian clinical trial has found that giving steroids in short bursts instead …

CAR-T cells enhanced with navigation system to penetrate lymph nodes more efficiently

[ Chimeric antigen receptor T-cell therapy, or CAR-T, has transformed treatment for blood cancers. The …

Leave a Reply

Available for Amazon Prime
Link. You have been rate limited for making too many requests in a short time frame.